Practitioner feedback on lung cancer practice guidelines in Ontario

Journal of Thoracic Oncology

Volumn 1, Issue 1, 2006, Pages 10-18

  Evans, William K ^a,c,e,f   Graham, Ian D ^b   Cameron, David ^c   Mackay, Jean A ^c   Brouwers, Mellissa ^d  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e CANCER CARE ONTARIO   (Canada)

^f JURAVINSKI CANCER CENTRE   (Canada)

Author keywords

Guidelines; Lung cancer; Practitioner feedback; Survey

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; GEMCITABINE; NAVELBINE; PACLITAXEL;

ARTICLE; CANADA; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; COMMUNITY CARE; GEOGRAPHY; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL SPECIALIST; MULTIMODALITY CANCER THERAPY; ONCOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONOLOGY; THORAX SURGERY; CLINICAL COMPETENCE; LUNG TUMOR; MESOTHELIOMA; QUESTIONNAIRE; RETROSPECTIVE STUDY; SMALL CELL CARCINOMA; STANDARD; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CLINICAL COMPETENCE; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; MESOTHELIOMA; ONTARIO; PRACTICE GUIDELINES; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34247866339     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/01243894-200601000-00005     Document Type: Article

References (26)

1. Woolf SH. Practice guidelines: a new reality in medicine: 1. Recent developments. Arch Intern Med 1990;150:1811-1818.
2. Browman GP, Levine MN, Mohide EA, et al. The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 1995;13:502-512.
3. Evans WK, Newman T, Graham ID, et al. Lung cancer practice guidelines: lessons learned and issues addressed by the Ontario Lung Cancer Disease Site group. J Clin Oncol 1997;153:3049-3059.
4. Lopez PG, Stewart DJ, Newman TE, et al. Chemotherapy in stage IV (metastatic) non-small cell lung cancer. Cancer Prev Control 1997;1:18-27.
5. Goss GD, Logan DM, Newman TE, et al. Use of vinorelbine in non-small cell lung cancer. Cancer Prev Control 1997;1:28-38.
6. Okawara G, Rusthoven J, Newman T, et al. Unresected stage III non-small cell lung cancer. Cancer Prev Control 1997;1:249-259.
7. Logan DM, Lochrin CA, Darling G, et al. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small cell lung cancer after complete resection. Cancer Prev Control 1997;1:366-378.
8. Goss G, Paszat L, Newman T, et al. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small cell lung cancer. Cancer Prev Control 1998;2:32-39.
9. Evans WK, Kocha W, Gagliardi A, et al. The use of gemcitabine in non-small-cell lung cancer. Cancer Prev Control 1999;3:84-94.
10. Okawara G, Gagliardi A, Evans WK, et al. The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small-cell lung cancer. Curr Oncol 2000;7:162-172.
11. Yu E, Lochrin C, Dixon P, et al. Altered fractionation of radical radiation therapy in the management of unresectable non-small-cell lung cancer. Curr Oncol 2000;7:98-109.
12. Logan D, Laurie S, Markman BR, et al. The role of single-agent docetaxel as second-line treatment for advanced non-small-cell lung cancer. Curr Oncol 2001;8:50-59.
13. Kotalik J, Yu E, Markman BR, et al. Practice guideline on prophylactic cranial irradiation in small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001;50:309-316.
14. Laurie SA, Logan D, Markman BR, et al. Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer. Lung Cancer 2004;43:223-240.
15. Okawara G, Ung YC, Markman BR, et al. Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline. Lung Cancer 2004;44:1-11.
16. Ellis P, Mackay JA, Evans WK, et al. Use of gemcitabine in non-small-cell lung cancer. Curr Oncol 2003;10:3-26.
17. Maziak DE, Markman BR, Mackay JA, et al. Photodynamic therapy in non-small cell lung cancer: a systematic review. Ann Thorac Surg 2004;77:1484-1491.
18. Chamberlain DW, Wenckebach GFC, Alexander F, et al. Pathological examination and the reporting of lung cancer specimens. Clin Lung Cancer 2000;1:261-268.
19. Brouwers MC, Graham ID, Hanna SE, et al. Clinicians' assessments of practice guidelines in oncology: the CAPGO survey. Int J Technol Assess Health Care 2004;20:421-426.
20. Taylor KM, Macdonald KG, Ng P, et al. The black box: physician response to breast cancer guidelines. Cancer Prev Control 1997;1:56-60.
21. Browman GP, Makarski J, Robinson P, et al. Practitioners as experts: the influence of practicing oncologists "in-the-field" on evidence-based guideline development. J Clin Oncol 2003;23:113-119.
22. Grimshaw JM, Eccles MP. Is evidence-based implementation of evidence-based care possible? Med J Aust 2004;180:S50-S51.
23. Lavis JN, Robertson D, Woodside JM, et al. How can research organizations more effectively transfer research knowledge to decision-makers? Milbank Q 2003;81:221-248.
24. Graham ID, Evans WK, Logan D, et al. Canadian oncologists and clinical practice guidelines: a national survey of attitudes and reported use. Oncology 2000;49:283-290.
25. Pater J, Browman GP, Brouwers MC, et al. Funding new cancer drugs in Ontario: closing the loop in the practice guidelines development cycle. J Clin Oncol 2001;19:3392-3396.
26. Evans WK, Nefsky M, Pater J, et al. Cancer Care Ontario's new drug funding program: controlled introduction of expensive anticancer drugs. Chronic Dis Can 2002;23:152-156.